Literature DB >> 15653816

Safety of the blood supply in Latin America.

Gabriel A Schmunis1, Jose R Cruz.   

Abstract

Appropriate selection of donors, use of sensitive screening tests, and the application of a mandatory quality assurance system are essential to maintain the safety of the blood supply. Laws, decrees, norms, and/or regulations covering most of these aspects of blood transfusion exist in 16 of the 17 countries in Latin America that are the subject of this review. In 17 countries, there is an information system that, although still incomplete (there are no official reports on adverse events and incidents), allows us to establish progress made on the status of the blood supply since 1993. Most advances originated in increased screening coverage for infectious diseases and better quality assurance. However, in 2001 to 2002, tainted blood may have caused infections in 12 of the 17 countries; no country reached the number of donors considered adequate, i.e., 5% of the population, to avoid blood shortages, or decreased significantly the number of blood banks, although larger blood banks are more efficient and take advantage of economies of scale. In those years, paid donors still existed in four countries and replacement donors made up >75% of the blood donors in another eight countries. In addition, countries did not report the number of voluntary donors who were repeat donors, i.e., the healthiest category. In spite of progress made, more improvements are needed.

Entities:  

Mesh:

Year:  2005        PMID: 15653816      PMCID: PMC544183          DOI: 10.1128/CMR.18.1.12-29.2005

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  68 in total

1.  [A study of sociocultural factors related to voluntary blood donation in the Americas].

Authors:  Marcela García Gutiérrez; Eugenia Sáenz de Tejada; José Ramiro Cruz
Journal:  Rev Panam Salud Publica       Date:  2003 Feb-Mar

2.  Impact of changes in viral marker screening assays.

Authors:  Usha K Sharma; Susan L Stramer; David J Wright; Simone A Glynn; Sigurd Hermansen; George B Schreiber; Steven H Kleinman; Michael P Busch
Journal:  Transfusion       Date:  2003-02       Impact factor: 3.157

3.  [Prevalence of infection by Trypanosoma cruzi in patients with multiple blood transfusions].

Authors:  M Lorca; J Lorca; R Child; A Atias; M Canales; E Lorca; J Gutiérrez
Journal:  Rev Med Chil       Date:  1988-02       Impact factor: 0.553

4.  [Evaluation of commercial kits used for Chagas disease diagnosis in blood banks in Chile. II. Routine application].

Authors:  M Lorca; R Child; A García; M Silva; L Martínez; G Jerez; I Toledo; D Mezzano
Journal:  Rev Med Chil       Date:  1994-08       Impact factor: 0.553

Review 5.  Chagas' disease and blood transfusion: a New World problem?

Authors:  S Wendel; A L Gonzaga
Journal:  Vox Sang       Date:  1993       Impact factor: 2.144

6.  Establishment and organization of a blood transfusion service.

Authors:  J Emmanuel
Journal:  Vox Sang       Date:  1994       Impact factor: 2.144

7.  Safety of blood supply for infectious diseases in Latin American countries, 1994-1997.

Authors:  G A Schmunis; F Zicker; J R Cruz; P Cuchi
Journal:  Am J Trop Med Hyg       Date:  2001-12       Impact factor: 2.345

8.  Availability, safety, and quality of blood for transfusion in the Americas.

Authors:  José Ramiro Cruz; María Dolores Pérez-Rosales
Journal:  Rev Panam Salud Publica       Date:  2003 Feb-Mar

9.  [Risk of transmission of Trypanosoma cruzi by blood transfusion in Mexico].

Authors:  C Guzmán Bracho; L García García; J Floriani Verdugo; S Guerrero Martínez; M Torres Cosme; C Ramírez Melgar; O Velasco Castrejón
Journal:  Rev Panam Salud Publica       Date:  1998-08

10.  Estimated risk of transmission of the human immunodeficiency virus by screened blood in the United States.

Authors:  E M Lackritz; G A Satten; J Aberle-Grasse; R Y Dodd; V P Raimondi; R S Janssen; W F Lewis; E P Notari; L R Petersen
Journal:  N Engl J Med       Date:  1995-12-28       Impact factor: 91.245

View more
  41 in total

1.  Arboprotozoae.

Authors: 
Journal:  Transfus Med Hemother       Date:  2009       Impact factor: 3.747

Review 2.  Chagas disease and transfusion medicine: a perspective from non-endemic countries.

Authors:  Andrea Angheben; Lucia Boix; Dora Buonfrate; Federico Gobbi; Zeno Bisoffi; Simonetta Pupella; Giorgio Gandini; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2015-10       Impact factor: 3.443

3.  The emergence of chagas disease in the United States and Canada.

Authors:  Louis V Kirchhoff; Richard D Pearson
Journal:  Curr Infect Dis Rep       Date:  2007-09       Impact factor: 3.725

Review 4.  Transmission of tropical and geographically restricted infections during solid-organ transplantation.

Authors:  P Martín-Dávila; J Fortún; R López-Vélez; F Norman; M Montes de Oca; P Zamarrón; M I González; A Moreno; T Pumarola; G Garrido; A Candela; S Moreno
Journal:  Clin Microbiol Rev       Date:  2008-01       Impact factor: 26.132

5.  Hepatitis B (HBV), hepatitis C (HCV) and hepatitis delta (HDV) viruses in the Colombian population--how is the epidemiological situation?

Authors:  Mónica Viviana Alvarado-Mora; María Fernanda Gutierrez Fernandez; Michele Soares Gomes-Gouvêa; Raymundo Soares de Azevedo Neto; Flair José Carrilho; João Renato Rebello Pinho
Journal:  PLoS One       Date:  2011-04-29       Impact factor: 3.240

6.  Demographic profile of blood donors at three major Brazilian blood centers: results from the International REDS-II study, 2007 to 2008.

Authors:  Anna Bárbara Carneiro-Proietti; Ester C Sabino; Divaldo Sampaio; Fernando A Proietti; Thelma T Gonçalez; Cláudia D L Oliveira; João E Ferreira; Jing Liu; Brian Custer; George B Schreiber; Edward L Murphy; Michael P Busch
Journal:  Transfusion       Date:  2009-12-10       Impact factor: 3.157

7.  Transfusion-transmitted parasitic infections.

Authors:  Gagandeep Singh; Rakesh Sehgal
Journal:  Asian J Transfus Sci       Date:  2010-07

Review 8.  New, improved treatments for Chagas disease: from the R&D pipeline to the patients.

Authors:  Isabela Ribeiro; Ann-Marie Sevcsik; Fabiana Alves; Graciela Diap; Robert Don; Michael O Harhay; Shing Chang; Bernard Pecoul
Journal:  PLoS Negl Trop Dis       Date:  2009-07-07

9.  Imported infectious diseases in mobile populations, Spain.

Authors:  Begoña Monge-Maillo; B Carolina Jiménez; José A Pérez-Molina; Francesca Norman; Miriam Navarro; Ana Pérez-Ayala; Juan M Herrero; Pilar Zamarrón; Rogelio López-Vélez
Journal:  Emerg Infect Dis       Date:  2009-11       Impact factor: 6.883

10.  Status of blood transfusion services in Iran.

Authors:  A Gharehbaghian; H Abolghasemi; M Tabrizi Namini
Journal:  Asian J Transfus Sci       Date:  2008-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.